FQ - 13th International Conference
Advanced Biomaterials and Nano-biotechnology for Medicine
Conveners:
Aldo BOCCACCINI, University of Erlangen-Nuernberg, Germany
Masahiro YOSHIMURA, National Cheng Kung University, Taiwan (Programme Chair)
Min WANG, The University of Hong Kong, Hong Kong
Members:
Serena BEST, University of Cambridge, UK
Marc BOHNER, RMS Foundation, Switzerland
Guoping CHEN, MIMS-MANA, Japan
Peilin CHEN, Research Center for Applied Sci., Academia Sinica, Taiwan
Yakai FENG, Tianjin University, China
John FISHER, University of Maryland, USA
Changyou GAO, Zhejiang University, China
Mingyuan GAO, Institute of Chemistry, CAS, China
Masakazu KAWASHITA, Tokyo Medical and Dental University, Japan
Sergei KULKOV, Institute of Strength Physics and Materials Science, Russia
Cato LAURENCIN, University of Connecticut, USA
Doo Sung LEE, Sungkyunkwan University, South Korea
Jin Ho LEE, Hannam University, South Korea
Pavel A. LEVKIN, Karlsruhe Institute of Technology, Germany
Jun LI, National University of Singapore, Singapore
Patrick T. MATHER, Penn State University, USA
Ji Ho (Joe) PARK, KAIST, South Korea
Pier Paolo POMPA, Italian Institute of Technology, Italy
Kurosch REZWAN, University of Bremen, Germany
Yasuhiko TABATA, Kyoto University, Japan
Maryam TABRIZIAN, McGill University, Canada
Vladimir P. TORCHILIN, Northeastern University, USA
YuHuang WANG, University of Maryland, USA
Thomas J. WEBSTER, Northeastern University, USA
Younan XIA, Georgia Institute of Technology, USA
Nobuhiko YUI, Tokyo Medical and Dental University, Japan
Lijie Grace ZHANG, George Washington University, USA
Aldo BOCCACCINI, University of Erlangen-Nuernberg, Germany
Masahiro YOSHIMURA, National Cheng Kung University, Taiwan (Programme Chair)
Min WANG, The University of Hong Kong, Hong Kong
Members:
Serena BEST, University of Cambridge, UK
Marc BOHNER, RMS Foundation, Switzerland
Guoping CHEN, MIMS-MANA, Japan
Peilin CHEN, Research Center for Applied Sci., Academia Sinica, Taiwan
Yakai FENG, Tianjin University, China
John FISHER, University of Maryland, USA
Changyou GAO, Zhejiang University, China
Mingyuan GAO, Institute of Chemistry, CAS, China
Masakazu KAWASHITA, Tokyo Medical and Dental University, Japan
Sergei KULKOV, Institute of Strength Physics and Materials Science, Russia
Cato LAURENCIN, University of Connecticut, USA
Doo Sung LEE, Sungkyunkwan University, South Korea
Jin Ho LEE, Hannam University, South Korea
Pavel A. LEVKIN, Karlsruhe Institute of Technology, Germany
Jun LI, National University of Singapore, Singapore
Patrick T. MATHER, Penn State University, USA
Ji Ho (Joe) PARK, KAIST, South Korea
Pier Paolo POMPA, Italian Institute of Technology, Italy
Kurosch REZWAN, University of Bremen, Germany
Yasuhiko TABATA, Kyoto University, Japan
Maryam TABRIZIAN, McGill University, Canada
Vladimir P. TORCHILIN, Northeastern University, USA
YuHuang WANG, University of Maryland, USA
Thomas J. WEBSTER, Northeastern University, USA
Younan XIA, Georgia Institute of Technology, USA
Nobuhiko YUI, Tokyo Medical and Dental University, Japan
Lijie Grace ZHANG, George Washington University, USA
Francesco BAINO, Politecnico di Torino, Italy
Cato LAURENCIN, University of Connecticut, USA
Patrick T. MATHER, Penn State University, USA
Andrew STECKL, University of Cincinnati, USA
Vladimir P. TORCHILIN, Northeastern University, USA
Djordje VELJOVIC, University of Belgrade, Serbia
Thomas WEBSTER, Northeastern University, USA (Keynote)
Masahiro YOSHIMURA, National Cheng Kung University, Taiwan
Cato LAURENCIN, University of Connecticut, USA
Patrick T. MATHER, Penn State University, USA
Andrew STECKL, University of Cincinnati, USA
Vladimir P. TORCHILIN, Northeastern University, USA
Djordje VELJOVIC, University of Belgrade, Serbia
Thomas WEBSTER, Northeastern University, USA (Keynote)
Masahiro YOSHIMURA, National Cheng Kung University, Taiwan
The convergences of materials, electronics and biological systems at the nanoscale are fuelling unprecedented opportunities in the biomedical field through groundbreaking inventions / innovations in diagnosis and therapy. Major objectives of this conference, which follows the conferences on the same subject held in previous CIMTEC editions, is to provide a synergic approach covering applied chemistry and physics, materials science, electronics, biochemistry and medicine to enlighten how deeper insights into biological events and their interplays with nanotechnology can support the development of new generations of materials, micro- or nano-devices, molecular level approaches and advanced characterizations to address major medical problems.
The conference particularly aims to report recent progress in the synthesis and characterization of new or creatively modified stimuli-responsive, active and multifunctional metals, ceramics, polymers, gels; smart nanoparticles, functionalized l-D and 2-D nanostructures, Q-dots; hybrids, composites, self-organized materials, hierarchical bio-nanostructures; as well as the potential for their implementation in selected challenging areas of nanomedicine such as (i) multi-scale approaches to regenerate and engineer new soft tissues and hard tissues, (ii) innovative targeted drug delivery and release platforms, and (iii) new materials and systems for medical diagnosis and therapy including multi-modal theranostics.
Three Focused Sessions on latest developments on implantable neural interfaces (FP-6), on wireless body sensor networks for healthcare applications (FP-7), and on progress in 3D bioprinting of soft tissues and organs (FP-8) will complement the Conference programme.
Overall, the study of systemic interactions in the body environment such as side effects, biocompatibility and biofunctionality will be essential issues to promote the discussion for bioinspired strategies in materials and device design to be effectively implemented into clinical practice.
The conference particularly aims to report recent progress in the synthesis and characterization of new or creatively modified stimuli-responsive, active and multifunctional metals, ceramics, polymers, gels; smart nanoparticles, functionalized l-D and 2-D nanostructures, Q-dots; hybrids, composites, self-organized materials, hierarchical bio-nanostructures; as well as the potential for their implementation in selected challenging areas of nanomedicine such as (i) multi-scale approaches to regenerate and engineer new soft tissues and hard tissues, (ii) innovative targeted drug delivery and release platforms, and (iii) new materials and systems for medical diagnosis and therapy including multi-modal theranostics.
Three Focused Sessions on latest developments on implantable neural interfaces (FP-6), on wireless body sensor networks for healthcare applications (FP-7), and on progress in 3D bioprinting of soft tissues and organs (FP-8) will complement the Conference programme.
Overall, the study of systemic interactions in the body environment such as side effects, biocompatibility and biofunctionality will be essential issues to promote the discussion for bioinspired strategies in materials and device design to be effectively implemented into clinical practice.
Session Topics
FQ-1 Advances in biomaterials: synthesis, processing, characterization, functionalization, finalization
- Bioactive, biodegradable, multifunctional ceramics, glasses, and metals
- Bioactive, biodegradable, stimuli-responsive, multifunctional polymers, gels, and elastomers, liquid crystalline polymers, composites, and hybrids
- Bioinspired, biomimetic, self-organized, hierarchical materials
- Microbiome-supporting and immunomodulatory material
- Multifunctional nanostructures and nanoparticles
- Modeling of biomaterials and their functions
FQ-2 Tissue engineering and regenerative medicine
- Biofabrication of cells and tissue constructs, multi-phase and multi-functional scaffolds, microfabrication techniques
- Vascularization of tissue engineered constructs
- Biomaterials for tissue interface regeneration (ligament/tendon/cartilage-to-bone)
- Biomaterials for modulating stem cell microenvironment
- Growth factor delivery vehicles
- Mechanistic effects of materials, cell attachment, proliferation, differentiation
- Biomimetic materials for engineering load-bearing tissues, self-healing mechanisms
- Biomechanics of soft tissues and hard tissues
- Evaluation of tissue engineering constructs in laboratory and/or pre-clinical settings
FQ-3 New therapeutics and intelligent drug/biomolecule/gene delivery systems
- Advances in system-responsive materials for delivery systems. Controlled release systems, triggering mechanisms
- Drug targeting, targeting and imaging agents to site-specific delivery
- Biomaterials constructs for temporally controlled release of multiple factors
- Progress in imprinted recognition release systems and implantable micro- or nano-delivery devices
- In vitro and in vivo studies, models for drug transport, absorption metabolism, retention mechanisms and toxicological issues
FQ-4 Bio-imaging and theranostics
• Inorganic and organic nanoparticulate systems for bio-imaging
• Functionalized agents/devices for in vitro and in vivo imaging and diagnostics
• Theranostic nanocarriers, multimodal theranostic agents
• Multifunctional theranostic nanoplatforms
• Biomedical imaging (MRI, MPI, PET, SPECT, ... )
• Functionalized agents/devices for in vitro and in vivo imaging and diagnostics
• Theranostic nanocarriers, multimodal theranostic agents
• Multifunctional theranostic nanoplatforms
• Biomedical imaging (MRI, MPI, PET, SPECT, ... )
- Muscoloskeletal, cardiovascular, nervous system, dentistry, ENT surgery, etc
- Modelling of tissue/implant system
- Biocompatibility, biodegradation, host response
- Qualification and testing methods
- Studies on retrieval implants
Focused Session FQ-6
Next Generation Implantable Neural Interfaces
Focused Session FQ-7
Wireless Body Sensor Networks for Healthcare Applications
Focused Session FQ-8
3D Bioprinting of Soft Tissues and Organs